Department of Anesthesiology, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen City, People's Republic of China.
Clin J Pain. 2024 Oct 1;40(10):601-606. doi: 10.1097/AJP.0000000000001235.
The transversus abdominis plane (TAP) block has proven efficacy and is an important component of multimodal analgesia in laparoscopic cholecystectomy (LC). The external oblique intercostal (EOI) block can provide a dermatomal sensory blockade of T6 to T10 using an anterior axillary line injection. The bilateral rectus sheath (RS) block can significantly reduce early postoperative pain caused by umbilical or periumbilical incisions. The current study aimed to compare the analgesic efficacies of ultrasound-guided subcostal TAP (UG-TAP) combined with the RS block and ultrasound-guided EOI (UG-EOI) combined with the RS block for LC.
Patients were randomly assigned to TAP or EOI group. Patients in TAP group received UG-TAP combined with an RS block. Patients in EOI group received UG-EOI combined with an RS block. The primary outcome was postoperative 24-hour sufentanil consumption.
A total of 49 patients were included in the final analysis. The postoperative 24-hour sufentanil consumption in the EOI group was significantly lower than that in the TAP group (9.79±10.22 vs. 18.67±12.58 µg; P [noninferiority] <0.01; noninferiority confirmed). Fewer patients in the EOI versus TAP group had a numerical rating score of >3 during motion. Furthermore, the mean postoperative 48-hour sufentanil consumption was lower in the EOI versus TAP group (11.54±11.70 vs. 23.04±17.10 µg; P =0.01). The mean postoperative 24-hour Quality of Recovery-15 score was higher in the EOI versus TAP group (135.21±4.40 vs. 131.91±5.11; P =0.02).
These findings suggest that UG-EOI combined with an RS block was superior to UG-TAP combined with an RS block for postoperative pain management in patients undergoing LC.
腹横肌平面(TAP)阻滞已被证实具有疗效,是腹腔镜胆囊切除术(LC)多模式镇痛的重要组成部分。肋间外肌(EOI)阻滞可通过腋前线注射为 T6 到 T10 提供感觉神经阻滞。双侧腹直肌鞘(RS)阻滞可显著减轻脐部或脐周切口引起的早期术后疼痛。本研究旨在比较超声引导下肋缘下 TAP(UG-TAP)联合 RS 阻滞与超声引导下 EOI(UG-EOI)联合 RS 阻滞在 LC 中的镇痛效果。
患者被随机分配到 TAP 或 EOI 组。TAP 组患者接受 UG-TAP 联合 RS 阻滞,EOI 组患者接受 UG-EOI 联合 RS 阻滞。主要结局是术后 24 小时舒芬太尼的消耗量。
共有 49 名患者纳入最终分析。EOI 组术后 24 小时舒芬太尼的消耗量明显低于 TAP 组(9.79±10.22 比 18.67±12.58μg;P[非劣效性]<0.01;非劣效性得到证实)。运动时 EOI 组数字评分法(NRS)>3 的患者较少。此外,EOI 组术后 48 小时舒芬太尼的消耗量低于 TAP 组(11.54±11.70 比 23.04±17.10μg;P=0.01)。EOI 组术后 24 小时的恢复质量-15 评分高于 TAP 组(135.21±4.40 比 131.91±5.11;P=0.02)。
这些发现表明,在接受 LC 的患者中,与 UG-TAP 联合 RS 阻滞相比,超声引导下 EOI 联合 RS 阻滞在术后疼痛管理方面更具优势。